Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trialSun Young Rha, Xiaochun Zhang, Marcelo Garrido et al.|The Lancet Oncology|2023Cited by 614
Evaluating Systemic Burnout in Medical Oncology Through a National Oncology Mentorship ProgramUdit Nindra, Jia Liu, Gowri Shivasabesan et al.|JCO Oncology Practice|2024Cited by 10
The Prognostic and Predictive Utility of CDX2 in Colorectal CancerWei Yen Chan, Stephanie Lim, Wei Chua et al.|International Journal of Molecular Sciences|2024Cited by 2
The Prognostic and Predictive Utility of CDX2 in Colorectal CancerWei Yen Chan, Stephanie Hui Lim, Kate Wilkinson et al.|Preprints.org|2024Cited by 1